Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression.
Bruni S, Mauro FL, Proietti CJ, Cordo-Russo RI, Rivas MA, Inurrigarro G, Dupont A, Rocha D, Fernández EA, Deza EG, Lopez Della Vecchia D, Barchuk S, Figurelli S, Lasso D, Friedrich AD, Santilli MC, Regge MV, Lebersztein G, Levit C, Anfuso F, Castiglione T, Elizalde PV, Mercogliano MF, Schillaci R. Bruni S, et al. Among authors: deza eg. J Immunother Cancer. 2023 Mar;11(3):e005325. doi: 10.1136/jitc-2022-005325. J Immunother Cancer. 2023. PMID: 36889811 Free PMC article.
TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer.
Mercogliano MF, De Martino M, Venturutti L, Rivas MA, Proietti CJ, Inurrigarro G, Frahm I, Allemand DH, Deza EG, Ares S, Gercovich FG, Guzmán P, Roa JC, Elizalde PV, Schillaci R. Mercogliano MF, et al. Among authors: deza eg. Clin Cancer Res. 2017 Feb 1;23(3):636-648. doi: 10.1158/1078-0432.CCR-16-0970. Epub 2016 Oct 3. Clin Cancer Res. 2017. PMID: 27698002
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF, Inurrigarro G, De Martino M, Venturutti L, Rivas MA, Cordo-Russo R, Proietti CJ, Fernández EA, Frahm I, Barchuk S, Allemand DH, Figurelli S, Deza EG, Ares S, Gercovich FG, Cortese E, Amasino M, Guzmán P, Roa JC, Elizalde PV, Schillaci R. Mercogliano MF, et al. Among authors: deza eg. BMC Cancer. 2017 Dec 28;17(1):895. doi: 10.1186/s12885-017-3897-x. BMC Cancer. 2017. PMID: 29281999 Free PMC article.
Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis.
Madera S, Chervo MF, Chiauzzi VA, Pereyra MG, Venturutti L, Izzo F, Roldán Deamicis A, Guzman P, Dupont A, Roa JC, Cenciarini ME, Barchuk S, Figurelli S, Lopez Della Vecchia D, Levit C, Lebersztein G, Anfuso F, Castiglioni T, Cortese E, Ares S, Deza EG, Gercovich FG, Proietti CJ, Schillaci R, Cordo Russo RI, Elizalde PV. Madera S, et al. Among authors: deza eg. Horm Cancer. 2020 Oct;11(5-6):218-239. doi: 10.1007/s12672-020-00392-4. Epub 2020 Jul 6. Horm Cancer. 2020. PMID: 32632815 Free PMC article.
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth.
Tkach M, Rosemblit C, Rivas MA, Proietti CJ, Díaz Flaqué MC, Mercogliano MF, Beguelin W, Maronna E, Guzmán P, Gercovich FG, Deza EG, Elizalde PV, Schillaci R. Tkach M, et al. Among authors: deza eg. Endocr Relat Cancer. 2013 Mar 22;20(2):197-212. doi: 10.1530/ERC-12-0194. Print 2013 Apr. Endocr Relat Cancer. 2013. PMID: 23329648 Free article.
Oncoplastic options in breast conservative surgery.
Rancati A, Gonzalez E, Angrigiani C, Gercovich G, Deza EG, Dorr J. Rancati A, et al. Among authors: deza eg. Gland Surg. 2013 Aug;2(3):163-9. doi: 10.3978/j.issn.2227-684X.2013.07.01. Gland Surg. 2013. PMID: 25083478 Free PMC article.
Colorectal carcinoma in children, adolescents, and young adults.
Chantada GL, Perelli VB, Lombardi MG, Amaral D, Cascallar D, Scopinaro M, Deza EG, Gercovich FG. Chantada GL, et al. Among authors: deza eg. J Pediatr Hematol Oncol. 2005 Jan;27(1):39-41. doi: 10.1097/01.mph.0000149251.68562.8e. J Pediatr Hematol Oncol. 2005. PMID: 15654277